Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data

Alia S. Dadabhai, Behnam Saberi, Katie Lobner, Russell T. Shinohara, Gerard Mullin

Research output: Contribution to journalReview article

Abstract

AIM To investigate the relationship between vitamin D and liver fibrosis in hepatitis C-monoinfected or hepatitis C virus (HCV)-human immunodeficiency virus (HIV) coinfected patients. METHODS Pertinent studies were located by a library literature search in PubMed/Embase/Cochrane/Scopus/LILACS by two individual reviewers. Inclusion criteria: (1) studies with patients with HCV or co-infected HCV/HIV; (2) studies with patients ≥ 18 years old; (3) studies that evaluated liver fibrosis stage, only based on liver biopsy; and (4) studies that reported serum or plasma 25(OH)D levels. Studies that included pediatric patients, other etiologies of liver disease, or did not use liver biopsy for fibrosis evaluation, or studies with inadequate data were excluded. Estimated measures of association reported in the literature, as well as corresponding measures of uncertainty, were recorded and corresponding odds ratios with 95%CI were included in a meta-analysis. RESULTS The pooled data of this systematic review showed that 9 of the 12 studies correlated advanced liver disease defined as a Metavir value of F3/4 with 25(OH) D level insufficiency. The meta-analysis indicated a significant association across studies. CONCLUSION Low vitamin D status is common in chronic Hepatitis C patients and is associated with advanced liver fibrosis.

Original languageEnglish (US)
Pages (from-to)278-287
Number of pages10
JournalWorld Journal of Hepatology
Volume9
Issue number5
DOIs
StatePublished - 2017

Fingerprint

Chronic Hepatitis C
Vitamin D
Liver Cirrhosis
Meta-Analysis
Clinical Trials
Hepacivirus
Liver Diseases
Biopsy
HIV-2
Hepatitis C
PubMed
Libraries
Uncertainty
Odds Ratio
HIV
Pediatrics
Liver
Serum

Keywords

  • Chronic hepatitis C
  • Hepatitis C virus
  • Liver fibrosis
  • Vitamin D

ASJC Scopus subject areas

  • Hepatology

Cite this

Influence of vitamin D on liver fibrosis in chronic hepatitis C : A systematic review and meta-analysis of the pooled clinical trials data. / Dadabhai, Alia S.; Saberi, Behnam; Lobner, Katie; Shinohara, Russell T.; Mullin, Gerard.

In: World Journal of Hepatology, Vol. 9, No. 5, 2017, p. 278-287.

Research output: Contribution to journalReview article

@article{7eab5bfb4f3c482aa95558e5e7ff4ec5,
title = "Influence of vitamin D on liver fibrosis in chronic hepatitis C: A systematic review and meta-analysis of the pooled clinical trials data",
abstract = "AIM To investigate the relationship between vitamin D and liver fibrosis in hepatitis C-monoinfected or hepatitis C virus (HCV)-human immunodeficiency virus (HIV) coinfected patients. METHODS Pertinent studies were located by a library literature search in PubMed/Embase/Cochrane/Scopus/LILACS by two individual reviewers. Inclusion criteria: (1) studies with patients with HCV or co-infected HCV/HIV; (2) studies with patients ≥ 18 years old; (3) studies that evaluated liver fibrosis stage, only based on liver biopsy; and (4) studies that reported serum or plasma 25(OH)D levels. Studies that included pediatric patients, other etiologies of liver disease, or did not use liver biopsy for fibrosis evaluation, or studies with inadequate data were excluded. Estimated measures of association reported in the literature, as well as corresponding measures of uncertainty, were recorded and corresponding odds ratios with 95{\%}CI were included in a meta-analysis. RESULTS The pooled data of this systematic review showed that 9 of the 12 studies correlated advanced liver disease defined as a Metavir value of F3/4 with 25(OH) D level insufficiency. The meta-analysis indicated a significant association across studies. CONCLUSION Low vitamin D status is common in chronic Hepatitis C patients and is associated with advanced liver fibrosis.",
keywords = "Chronic hepatitis C, Hepatitis C virus, Liver fibrosis, Vitamin D",
author = "Dadabhai, {Alia S.} and Behnam Saberi and Katie Lobner and Shinohara, {Russell T.} and Gerard Mullin",
year = "2017",
doi = "10.4254/wjh.v9.i5.278",
language = "English (US)",
volume = "9",
pages = "278--287",
journal = "World Journal of Hepatology",
issn = "1948-5182",
publisher = "Baishideng Publishing Group",
number = "5",

}

TY - JOUR

T1 - Influence of vitamin D on liver fibrosis in chronic hepatitis C

T2 - A systematic review and meta-analysis of the pooled clinical trials data

AU - Dadabhai, Alia S.

AU - Saberi, Behnam

AU - Lobner, Katie

AU - Shinohara, Russell T.

AU - Mullin, Gerard

PY - 2017

Y1 - 2017

N2 - AIM To investigate the relationship between vitamin D and liver fibrosis in hepatitis C-monoinfected or hepatitis C virus (HCV)-human immunodeficiency virus (HIV) coinfected patients. METHODS Pertinent studies were located by a library literature search in PubMed/Embase/Cochrane/Scopus/LILACS by two individual reviewers. Inclusion criteria: (1) studies with patients with HCV or co-infected HCV/HIV; (2) studies with patients ≥ 18 years old; (3) studies that evaluated liver fibrosis stage, only based on liver biopsy; and (4) studies that reported serum or plasma 25(OH)D levels. Studies that included pediatric patients, other etiologies of liver disease, or did not use liver biopsy for fibrosis evaluation, or studies with inadequate data were excluded. Estimated measures of association reported in the literature, as well as corresponding measures of uncertainty, were recorded and corresponding odds ratios with 95%CI were included in a meta-analysis. RESULTS The pooled data of this systematic review showed that 9 of the 12 studies correlated advanced liver disease defined as a Metavir value of F3/4 with 25(OH) D level insufficiency. The meta-analysis indicated a significant association across studies. CONCLUSION Low vitamin D status is common in chronic Hepatitis C patients and is associated with advanced liver fibrosis.

AB - AIM To investigate the relationship between vitamin D and liver fibrosis in hepatitis C-monoinfected or hepatitis C virus (HCV)-human immunodeficiency virus (HIV) coinfected patients. METHODS Pertinent studies were located by a library literature search in PubMed/Embase/Cochrane/Scopus/LILACS by two individual reviewers. Inclusion criteria: (1) studies with patients with HCV or co-infected HCV/HIV; (2) studies with patients ≥ 18 years old; (3) studies that evaluated liver fibrosis stage, only based on liver biopsy; and (4) studies that reported serum or plasma 25(OH)D levels. Studies that included pediatric patients, other etiologies of liver disease, or did not use liver biopsy for fibrosis evaluation, or studies with inadequate data were excluded. Estimated measures of association reported in the literature, as well as corresponding measures of uncertainty, were recorded and corresponding odds ratios with 95%CI were included in a meta-analysis. RESULTS The pooled data of this systematic review showed that 9 of the 12 studies correlated advanced liver disease defined as a Metavir value of F3/4 with 25(OH) D level insufficiency. The meta-analysis indicated a significant association across studies. CONCLUSION Low vitamin D status is common in chronic Hepatitis C patients and is associated with advanced liver fibrosis.

KW - Chronic hepatitis C

KW - Hepatitis C virus

KW - Liver fibrosis

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=85013491471&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013491471&partnerID=8YFLogxK

U2 - 10.4254/wjh.v9.i5.278

DO - 10.4254/wjh.v9.i5.278

M3 - Review article

C2 - 28261385

AN - SCOPUS:85013491471

VL - 9

SP - 278

EP - 287

JO - World Journal of Hepatology

JF - World Journal of Hepatology

SN - 1948-5182

IS - 5

ER -